Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Retained Earnings (2018 - 2019)

Historic Retained Earnings for DiaMedica Therapeutics (DMAC) over the last 2 years, with Q3 2019 value amounting to -$54.1 million.

  • DiaMedica Therapeutics' Retained Earnings changed N/A to -$54.1 million in Q3 2019 from the same period last year, while for Sep 2019 it was -$54.1 million, marking a year-over-year change of. This contributed to the annual value of -$46.0 million for FY2018, which is N/A changed from last year.
  • Per DiaMedica Therapeutics' latest filing, its Retained Earnings stood at -$54.1 million for Q3 2019.
  • In the past 5 years, DiaMedica Therapeutics' Retained Earnings registered a high of -$46.0 million during Q4 2018, and its lowest value of -$54.1 million during Q3 2019.